Cocrystal Structures of Diaminopimelate Decarboxylase

  • Ray S
  • Bonanno J
  • Rajashankar K
  • et al.
Citations of this article
Mendeley users who have this article in their library.


Cocrystal structures of Methanococcus jannaschii diaminopimelate decarboxylase (DAPDC) bound to a substrate analog, azelaic acid, and its L-lysine product have been determined at 2.6 Å and 2.0 Å, respectively. This PLP-dependent enzyme is responsible for the final step of L-lysine biosynthesis in bacteria and plays a role in β-lactam antibiotic resistance in Staphylococcus aureus. Substrate specificity derives from recognition of the L-chiral center of diaminopimelate and a system of ionic “molecular rulers” that dictate substrate length. A coupled-enzyme assay system permitted measurement of kinetic parameters for recombinant DAPDCs and inhibition constants (Ki) for azelaic acid (89 μM) and other substrate analogs. Implications for rational design of broad-spectrum antimicrobial agents targeted against DAPDCs of drug-resistant strains of bacterial pathogens, such as Staphylococcus aureus, are discussed.




Ray, S. S., Bonanno, J. B., Rajashankar, K. R., Pinho, M. G., He, G., De Lencastre, H., … Burley, S. K. (2002). Cocrystal Structures of Diaminopimelate Decarboxylase. Structure, 10(11), 1499–1508.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free